
HIV prevention drug hailed as breakthrough, but who gets access?
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPZy1yeVdnelVaUUM2YV95QjItdm43a29GN1lXSkVfV2dybk1OTjJnMlJWREd6TzMxTENtVmhOY0J0Ty1QLVRXVlFGbVB2S2lpZjRSS24tTG56ZV96V0JzZ0F4OE1JM1ZIUWtYeTZKUVpyZVRzUVhqYUFEOUFoVjZIeldWcFo1VHBCemFpRGhrYkd3OFNaRDY1Q1ppaUxDcFY5SncwdkZR0gGrAUFVX3lxTE0xLVJXc1RCLWItdURIUXdFcm1sdTg4cmFKdlREaDVOaEY4VHJ6WVJTTGhlWVY2VF9wSkxGXzkxQWlhTjl6VGNJbjJqSEIzNUFpX2loYjRTOGhCREtScFFCN1Q3Vlhfcl9venNrUUUzMU84MDFzZzA4OEZ6d0J3NUVZajdLX3dRNDNCNEp2ZUMwcGRHWmRoTTZGNFFUR202QkI5SjdOVWs3Z0FRZw?oc=5" target="_blank">HIV prevention drug hailed as breakthrough, but who gets access?</a>&nbsp;&nbsp;<font color="#6f6f6f">Al Jazeera</font>


